These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6181343)

  • 1. Effects of dopamine, N-N-di-n-propyl dopamine, and (R)- and (S)-sulpiride on guinea pig blood pressure.
    Horn PT; Kohli JD; Goldberg LI
    J Cardiovasc Pharmacol; 1982; 4(4):668-75. PubMed ID: 6181343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the cardiovascular actions of N,N-di-n-propyl dopamine and sodium nitroprusside in conscious and chloralose-anaesthetised dogs.
    O'Connor SE; Smith GW; Brown RA
    J Cardiovasc Pharmacol; 1982; 4(3):493-9. PubMed ID: 6177948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypotensive effects of N,N-din-n-propylodopamine in the anesthetized dog: comparison with sodium nitroprusside.
    Fennell WH; Kohli JD; Goldberg LI
    J Cardiovasc Pharmacol; 1980; 2(3):247-55. PubMed ID: 6156323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure lowering effects of N,N-di-n-propyl-dopamine in rats: evidence for stimulation of peripheral dopamine receptors leading to inhibition of sympathetic vascular tone.
    Cavero I; Lefèvre-Borg F; Gomeni R
    J Pharmacol Exp Ther; 1981 Aug; 218(2):515-24. PubMed ID: 7252851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facilitation of ganglionic transmission by sulpiride: evidence for an inhibitory role of dopamine in the canine sympathetic ganglion.
    Horn PT; Kohli JD; Goldberg LI
    J Pharmacol Exp Ther; 1982 Nov; 223(2):462-8. PubMed ID: 6290639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primate cardiovascular responses mediated by dopamine receptors: effects of N,N-di-n-propyldopamine and LY171555.
    Hahn RA; MacDonald BR
    J Pharmacol Exp Ther; 1984 Apr; 229(1):132-8. PubMed ID: 6707929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of peripheral dopamine receptors in rats: a mechanism for novel antihypertensive agents.
    Lefèvre-Borg F; Cavero I
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():291s-294s. PubMed ID: 7449273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N,N-Di-n-propyl dopamine: a qualitatively different dopamine vascular agonist.
    Kohli JD; Goldberg LI; Volkman PH; Cannon JG
    J Pharmacol Exp Ther; 1978 Oct; 207(1):16-22. PubMed ID: 702336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of presynaptic receptors in the cardiovascular actions of N,N-di-n-propyldopamine in the cat and dog.
    Massingham R; Dubocovich ML; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Oct; 314(1):17-28. PubMed ID: 7442823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms mediating the positive inotropic and chronotropic changes induced by dopexamine in the anesthetized dog.
    Bass AS; Kohli JD; Lubbers N; Goldberg LI
    J Pharmacol Exp Ther; 1987 Sep; 242(3):940-4. PubMed ID: 2888876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consistent unmasking of dopamine-induced dilation of the canine femoral vascular bed.
    Listinsky JJ; Kohli JD; Goldberg LI
    J Pharmacol Exp Ther; 1980 Dec; 215(3):662-7. PubMed ID: 6108364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of peripheral dopamine receptor and alpha-adrenoceptor blocking activity of sulpiride.
    Barrett RJ; Ginos JZ; Lokhandwala MF
    Eur J Pharmacol; 1982 Apr; 79(3-4):273-81. PubMed ID: 6124431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration in ocular function induced by phenylethylamine analogs of dopamine.
    Potter DE; Burke JA; Chang FW
    Curr Eye Res; 1984 Jun; 3(6):851-9. PubMed ID: 6329603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pressor response mediated via histamine H1-receptors of the guinea-pig sympathetic ganglia.
    Krstić MK
    Neuropharmacology; 1988 Dec; 27(12):1215-9. PubMed ID: 2907615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
    Cavero I; Lorrain J; Di Paola ED; Lhoste F; Payen B; Dennis T; Scatton B
    J Pharmacol Exp Ther; 1985 Dec; 235(3):798-809. PubMed ID: 2934543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central and peripheral dopaminergic mechanisms in the cardiovascular actions of pergolide in neurogenic hypertensive dogs.
    Barrett RJ; Lokhandwala MF
    Eur J Pharmacol; 1983 Dec; 96(3-4):211-26. PubMed ID: 6676105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
    Cavero I; Lefevre-Borg F; Lhoste F; Sabatier C; Richer C; Giudicelli JF
    J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic hemodynamic and regional blood flow effects of LY141865, a selective dopamine receptor agonist.
    Hahn RA; MacDonald BR
    J Pharmacol Exp Ther; 1984 Sep; 230(3):558-68. PubMed ID: 6470973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the cardiovascular actions of dopamine and epinine in the dog.
    Itoh H; Kohli JD; Rajfer SI; Goldberg LI
    J Pharmacol Exp Ther; 1985 Apr; 233(1):87-93. PubMed ID: 2858584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chronic infusion of hexamethonium and phenylephrine to effectively clamp sympathetic vasomotor tone. A novel approach.
    Collister JP; Osborn JW
    J Pharmacol Toxicol Methods; 1999 Nov; 42(3):135-47. PubMed ID: 10964011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.